Best Casino Sites Not On GamstopUK Casino Not On GamstopCasinos Not On GamstopNon Gamstop CasinosNon Gamstop CasinosNon Gamstop Casinos

Lonrho in gem ploy

Companies: LAF ��
11/04/2006

David Lenigas, boss of Lonrho Africa, has negotiated a �1.5 million investment in southern Africa-focused Nare Diamonds.

AIM-quoted Lonrho, which recently spent �5 million on ten per cent of imminent AIM uranium float Brinkley Mining, is taking 17 per cent of Nare at 10.4p. Nare is headed by Charles Mostert, ex-head of Petra Diamonds' acquisition Crown Diamonds, and has 80 per cent of South Africa's formerly productive Schmidtsdrift diamond mine, which started producing gems again last month.

The company also has interests in other diamond projects in the region, such as Klipspringer, Groen River and the Kamfersdam kimberlite pipe and tailings operation. This investment is part of Lenigas' strategy to beef up Lonrho Africa in resources, infrastructure and upmarket tourism in southern Africa and should bring some cheer to the shares, up 1p today at 22.5p.

Robert Tyerman

People who read this article also read ...
21/04/2006
11/04/2006
10/04/2006
10/04/2006
30/03/2006

AIM�42.94m 27.25p -6.50p
Other company articles:
21/04/2006
11/04/2006
10/04/2006
30/03/2006
15/03/2006

Sponsored Listings

Invest in the Stock Market at TD Waterhouse Open an account with TD Waterhouse and get two months commission free share trading. Trading accounts available online today.

Trade US Stocks with City Index City Index spread betting - tax free dealing in shares, indices no commission, no stamp duty and CFDs (contracts for difference).

Commission-Free CFD Trading in Shares and Indices Our award-winning trading platform offers free charting, news, analysis and mobile trading. CMC Markets UK Plc is authorised and regulated by the Financial Services Authority.

Recommendations

Dermasalve Sciences

AVOID

Aveva Group

HOLD

Orpak Systems

SPECULATIVE BUY

Gaming Corporation

SPECULATIVE BUY

Cosentino Signature Wines

BUY

SCS Upholstery

HOLD

Zi Medical

SPECULATIVE BUY

Phynova

SPECULATIVE BUY

Immunodiagnostic Systems

HOLD

Concurrent Technologies

BUY
AIM